Sanofi-Aventis to Build China Presence through Partnerships

Sanofi-Aventis recently announced it has established a regional R&D center in Shanghai. Unlike many of its big pharma competitors, Sanofi-Aventis is not building a lab and hiring scores of scientists to work exclusively on S-A projects. Instead, the company is focused on developing collaborations, a strategy that allows it to build on China’s innovative biopharma culture. More details... Stock Symbol: (NYSE: SNY)